| Efficacy, safety, and biomarkers of response to azacitidine and nivolumab in relapsed/refractory acute myeloid leukemia: a nonrandomized, open-label, phase II study N Daver, G Garcia-Manero, S Basu, PC Boddu, M Alfayez, JE Cortes, ... Cancer discovery 9 (3), 370-383, 2019 | 449 | 2019 |
| Safety and activity of ibrutinib plus rituximab for patients with high-risk chronic lymphocytic leukaemia: a single-arm, phase 2 study JA Burger, MJ Keating, WG Wierda, E Hartmann, J Hoellenriegel, ... The Lancet Oncology 15 (10), 1090-1099, 2014 | 430 | 2014 |
| Results of the phase I trial of RG7112, a small-molecule MDM2 antagonist in leukemia M Andreeff, KR Kelly, K Yee, S Assouline, R Strair, L Popplewell, ... Clinical Cancer Research 22 (4), 868-876, 2016 | 329 | 2016 |
| Association of measurable residual disease with survival outcomes in patients with acute myeloid leukemia: a systematic review and meta-analysis NJ Short, S Zhou, C Fu, DA Berry, RB Walter, SD Freeman, CS Hourigan, ... JAMA oncology 6 (12), 1890-1899, 2020 | 255 | 2020 |
| Randomized trial of ibrutinib vs ibrutinib plus rituximab in patients with chronic lymphocytic leukemia JA Burger, M Sivina, N Jain, E Kim, T Kadia, Z Estrov, ... Blood, The Journal of the American Society of Hematology 133 (10), 1011-1019, 2019 | 241 | 2019 |
| The impact of age and gender on papillary thyroid cancer survival J Jonklaas, G Nogueras-Gonzalez, M Munsell, D Litofsky, KB Ain, ... The Journal of Clinical Endocrinology & Metabolism 97 (6), E878-E887, 2012 | 230 | 2012 |
| Impact of BCR-ABL transcript type on outcome in patients with chronic-phase CML treated with tyrosine kinase inhibitors P Jain, H Kantarjian, KP Patel, GN Gonzalez, R Luthra, RK Shamanna, ... Blood, The Journal of the American Society of Hematology 127 (10), 1269-1275, 2016 | 172 | 2016 |
| Cytokine panel for response to intravesical therapy (CyPRIT): nomogram of changes in urinary cytokine levels predicts patient response to Bacillus Calmette-Guérin AM Kamat, J Briggman, DL Urbauer, R Svatek, GMN González, ... European Urology 69 (2), 197-200, 2016 | 166 | 2016 |
| Randomized trial of endobronchial ultrasound–guided transbronchial needle aspiration under general anesthesia versus moderate sedation RF Casal, DR Lazarus, K Kuhl, G Nogueras-González, S Perusich, ... American journal of respiratory and critical care medicine 191 (7), 796-803, 2015 | 151 | 2015 |
| Prognostic factors and survival outcomes in patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era: Cohort study of 477 patients P Jain, HM Kantarjian, A Ghorab, K Sasaki, EJ Jabbour, ... Cancer 123 (22), 4391-4402, 2017 | 147 | 2017 |
| Accuracy of colposcopy in the diagnostic setting compared with the screening setting SB Cantor, M Cárdenas-Turanzas, DD Cox, EN Atkinson, ... Obstetrics & Gynecology 111 (1), 7-14, 2008 | 146 | 2008 |
| Evaluating women with ovarian cancer for BRCA1 and BRCA2 mutations: missed opportunities LA Meyer, ME Anderson, RA Lacour, A Suri, MS Daniels, DL Urbauer, ... Obstetrics & Gynecology 115 (5), 945-952, 2010 | 142 | 2010 |
| Age and body mass index are independent risk factors for the development of postoperative paralytic ileus after radical cystectomy RS Svatek, MB Fisher, MB Williams, SF Matin, AM Kamat, HB Grossman, ... Urology 76 (6), 1419-1424, 2010 | 139 | 2010 |
| Selective reoperation for locally recurrent or metastatic pancreatic ductal adenocarcinoma following primary pancreatic resection RM Thomas, MJ Truty, GM Nogueras-Gonzalez, JB Fleming, JN Vauthey, ... Journal of Gastrointestinal Surgery 16 (9), 1696-1704, 2012 | 122 | 2012 |
| Radiographic tumor–vein interface as a predictor of intraoperative, pathologic, and oncologic outcomes in resectable and borderline resectable pancreatic cancer HST Cao, A Balachandran, H Wang, CE Bailey, JE Lee, PWT Pisters, ... Journal of Gastrointestinal Surgery 18 (2), 269-278, 2014 | 116 | 2014 |
| Preliminary report of a randomized dose escalation trial for prostate cancer using hypofractionation DA Kuban, GM Nogueras-Gonzalez, L Hamblin, AK Lee, S Choi, SJ Frank, ... International Journal of Radiation Oncology, Biology, Physics 78 (3), S58-S59, 2010 | 116 | 2010 |
| Prospective multicenter randomized intermediate biomarker study of oral contraceptive versus depo-provera for prevention of endometrial cancer in women with Lynch syndrome KH Lu, DS Loose, MS Yates, GM Nogueras-Gonzalez, MF Munsell, ... Cancer prevention research 6 (8), 774-781, 2013 | 115 | 2013 |
| Ponatinib as first-line treatment for patients with chronic myeloid leukaemia in chronic phase: a phase 2 study P Jain, H Kantarjian, E Jabbour, GN Gonzalez, G Borthakur, ... The Lancet Haematology 2 (9), e376-e383, 2015 | 110 | 2015 |
| Safety of presurgical targeted therapy in the setting of metastatic renal cell carcinoma BF Chapin, SE Delacroix Jr, SH Culp, GMN Gonzalez, NM Tannir, ... European urology 60 (5), 964-971, 2011 | 110 | 2011 |
| Analysis of cardiovascular and arteriothrombotic adverse events in chronic-phase CML patients after frontline TKIs P Jain, H Kantarjian, PC Boddu, GM Nogueras-González, S Verstovsek, ... Blood advances 3 (6), 851-861, 2019 | 109 | 2019 |
Guillermo Garcia-ManeroMD Anderson Cancer CenterVerified email at mdanderson.org
